Anivamersen

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAnivamersen
Drug Alias Nameanivamersenum阿尼伐生阿尼美生Pegnivacoginanivamersen +[11] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionFactor IXa inhibitors
TargetsCoagulation factor IX
Therapy Area/IndicationsCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArchemix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegado Biosciences Inc
Active IndicationsN/A
Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksKEGG